Zoetis Inc.
A maker of medicines, vaccines, and diagnostics for animals, Zoetis sells well-known products like the dog itch-relief drugs Apoquel and Cytopoint and Simparica parasite preventives to veterinarians worldwide. Born in the 1950s as the animal health arm of Pfizer, it became a fully independent company in 2013. Its name comes from the Greek word "zoe," meaning life—a fitting nod to its mission of keeping animals healthy.
Granted 134.3K · Sold 46.4K
Granted 7.0K · Bought 3.0K
Granted 6.0K · Sold 9.9K
Granted 7.0K · Bought 2.0K
Granted 39.9K
Bought 6.7K
Granted 19.2K
Granted 7.0K
Granted 9.3K · Sold 15.3K
Granted 21.5K
Granted 7.0K · Sold 2.6K
Granted 5.4K
Granted 2.4K
Granted 4.5K
Granted 7.0K
Granted 7.5K · Sold 3.5K
Granted 4.2K
Granted 5.8K
Granted 3.1K
Granted 3.7K
Granted 3.8K
Granted 2.8K
Granted 1.6K
Granted 454
Granted 1.5K
Granted 895
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Peck Kristin CChief Executive Officer, Director · 28 transactions | +49.9% | 105.9K | 134.3K | — | 46.4K |
| McCallister Michael BDirector · 14 transactions | — | 39.3K | 7.0K | 3.0K | — |
| Chen Heidi C.Executive Vice President · 7 transactions | -13.4% | 32.4Kas of Feb 2024 | 6.0K | — | 9.9K |
| Bisaro PaulDirector · 6 transactions | +48% | 27.9K | 7.0K | 2.0K | — |
| Joseph WettenyChief Financial Officer · 18 transactions | — | 22.8K | 39.9K | — | — |
| Damelio Frank ADirector · 1 transaction | +44.9% | 21.5K | — | 6.7K | — |
| Parent Louise MDirector · 12 transactions | +45.4% | 18.2K | 19.2K | — | — |
| Norden GregoryDirector · 13 transactions | +41.6% | 18.2K | 7.0K | — | — |
| Lagano RoxanneExecutive Vice President · 35 transactions | -39.4% | 16.5K | 9.3K | — | 15.3K |
| Scully Robert WDirector · 7 transactions | -27.7% | 13.1Kas of May 2025 | 21.5K | — | — |
| Reed Willie MDirector · 7 transactions | +53% | 12.9K | 7.0K | — | 2.6K |
| Rhodes LindaDirector · 6 transactions | +59.7% | 11.7Kas of May 2024 | 5.4K | — | — |
| Driscoll RimmaExecutive Vice President · 18 transactions | +47.2% | 5.9K | 2.4K | — | — |
| Mamilli WafaaExecutive Vice President · 6 transactions | +29.9% | 5.7Kas of Feb 2024 | 4.5K | — | — |
| Leatherberry Antoinette ReneeDirector · 10 transactions | — | 5.3K | 7.0K | — | — |
| Polzer Robert JExecutive Vice President · 15 transactions | +53% | 5.2Kas of Feb 2025 | 7.5K | — | 3.5K |
| Brannan JamieExecutive Vice President · 18 transactions | +189% | 4.3K | 4.2K | — | — |
| Broadhurst VanessaDirector · 8 transactions | — | 3.9K | 5.8K | — | — |
| Hattersley GavinDirector · 3 transactions | — | 3.4K | 3.1K | — | — |
| Sarbaugh KeithExecutive Vice President · 10 transactions | — | 3.3K | 3.7K | — | — |
| Ashton NicholasExecutive Vice President · 20 transactions | — | 2.2K | 3.8K | — | — |
| Ferran Astorga JeannetteExecutive Vice President · 20 transactions | — | 1.9K | 2.8K | — | — |
| Stetter MarkDirector · 1 transaction | — | 1.6K | 1.6K | — | — |
| Esch KevinExecutive Vice President · 8 transactions | — | 1.1K | 454 | — | — |
| Fuller JulieExecutive Vice President · 4 transactions | — | 1.1K | 1.5K | — | — |
| Banque Soria EsterExecutive Vice President · 2 transactions | — | 895as of Jul 2024 | 895 | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: -66.0K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.